SCHEMBL15940677

SCHEMBL15940677

C#Cc1nc2ccccc2cc1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 5/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
TDP1 Q9NUW8 3/20 0.47
HPGD P15428 4/20 0.43
MAPT P10636 3/20 0.43
GLA P06280 2/20 0.43
ACHE P22303 1/20 0.43
PDE10A Q9Y233 1/20 0.43
KMT2A Q03164 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MEN1 O00255 2/20 0.42
LMNA P02545 2/20 0.41
ATM Q13315 1/20 0.41
AKT1 P31749 1/20 0.40
PSMB5 P28074 3/20 0.40
NPSR1 Q6W5P4 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7020016 0.82 ALDH1A1 (0.47) ALDH1A1KDM4EL3MBTL1TDP1HPGD
SCHEMBL18024022 0.74 TDP1 (0.53) ALDH1A1KDM4ETDP1HPGDMAPT
SCHEMBL3359420 0.73 PSMB5 (0.65) ALDH1A1KDM4EL3MBTL1TDP1HPGD
SCHEMBL29374375 0.73 PSMB5 (0.65) ALDH1A1KDM4EL3MBTL1TDP1HPGD
SCHEMBL10816949 0.72 KDM4E (0.53) ALDH1A1KDM4EL3MBTL1TDP1HPGD
SCHEMBL8574353 0.72 KMT2A (0.74) ALDH1A1KDM4EL3MBTL1TDP1HPGD
SCHEMBL7369914 0.72 ALDH1A1 (0.51) ALDH1A1KDM4EL3MBTL1TDP1HPGD
SCHEMBL31054483 0.72 PSMB5 (0.63) ALDH1A1KDM4EL3MBTL1TDP1HPGD
SCHEMBL7071941 0.72 PSMB5 (0.71) ALDH1A1KDM4EL3MBTL1TDP1HPGD
SCHEMBL5258959 0.72 ALDH1A1 (0.51) ALDH1A1KDM4EL3MBTL1TDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9879004-B2 Substituted acetylene derivatives and their use as positive allosteric modulators of mGluR4 MERCK PATENT GMBH (DE) 2018-01-30 US disclosed
US-20150376182-A1 Substituted Acetylene Derivatives and their Use as Positive Allosteric Modulators of mGluR4 MERCK PATENT GMBH (DE) 2015-12-31 US disclosed
EP-2953933-A1 SUBSTITUTED ACETYLENE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR4 Merck Patent GmbH (DE) 2015-12-16 EP disclosed
WO-2014121883-A1 SUBSTITUTED ACETYLENE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR4 MERCK PATENT GMBH (DE) 2014-08-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376182-A1 Substituted Acetylene Derivatives and their Use as Positive Allosteric Modulators of mGluR4 GRM4, GRIA4, GRIK4 ALDH1A1 3648/4885KDM4E 609/4885L3MBTL1 3402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.